University of Leicester
Browse
Therapeutic cancer prevention: achievements and ongoing challenges - a focus on breast and colorectal cancer.pdf (349.74 kB)

Therapeutic cancer prevention: achievements and ongoing challenges - a focus on breast and colorectal cancer.

Download (349.74 kB)
journal contribution
posted on 2019-06-18, 09:15 authored by Davide Serrano, Bernardo Bonanni, Karen Brown
The constant increase of cancer incidence and the huge costs of new treatments make cancer prevention a crucial goal in order to maintain sustainable public health systems across the world. Carcinogenesis is a multistep process, which allows time for active intervention with natural or synthetic agents to stop or reverse the pathological process. Cancer prevention medicine can be considered to be treatment of premalignant cells or preneoplastic conditions. Clearly such interventions require well-defined risk classification so that personalized strategies and specific treatments can be applied to cohorts with a documented increased cancer risk, and not to the general population as a whole. Further development of these strategies in an efficient and timely manner requires investment in the discovery and validation of surrogate cancer biomarkers with both prognostic and predictive value to detect and monitor the efficacy of interventions in clinical trials and beyond. In the field of cancer prevention medicine, breast and colon cancer demonstrates the strongest clinical evidence that pharmacological intervention can lower cancer risk. Here, we offer an overview of the major clinical achievements for these cancers and the critical issues to improve implementation and clinical uptake of efficacious therapies, as well as further developments needed in the field of preventive medicine.

Funding

Karen Brown is supported by and represents the ECMC UK Therapeutic Cancer Prevention Network. Bernardo Bonanni is supported by Italian Ministry of Health.

History

Citation

Molecular Oncology, 2019, 13 (3), pp. 579-590

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Cancer Research Centre

Version

  • VoR (Version of Record)

Published in

Molecular Oncology

Publisher

Wiley, Federation of European Biochemical Societies

eissn

1878-0261

Acceptance date

2019-01-19

Copyright date

2019

Available date

2019-06-18

Publisher version

https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12461

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC